BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26259120)

  • 1. Health-related quality of life and blood pressure 12 months after renal denervation.
    Lambert GW; Hering D; Marusic P; Thorp A; Sata Y; Lee R; Duval J; Hammond L; Head GA; Esler MD; Lambert EA; Dixon JB; Dhar AK; Barton DA; Schlaich MP
    J Hypertens; 2015 Nov; 33(11):2350-8. PubMed ID: 26259120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
    Mahfoud F; Ukena C; Schmieder RE; Cremers B; Rump LC; Vonend O; Weil J; Schmidt M; Hoppe UC; Zeller T; Bauer A; Ott C; Blessing E; Sobotka PA; Krum H; Schlaich M; Esler M; Böhm M
    Circulation; 2013 Jul; 128(2):132-40. PubMed ID: 23780578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life after renal denervation in patients with treatment-resistant hypertension.
    Lambert GW; Hering D; Esler MD; Marusic P; Lambert EA; Tanamas SK; Shaw J; Krum H; Dixon JB; Barton DA; Schlaich MP
    Hypertension; 2012 Dec; 60(6):1479-84. PubMed ID: 23071129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension.
    Lambert T; Gammer V; Nahler A; Blessberger H; Kammler J; Grund M; Kerschner K; Buchmayr G; Saleh K; Kypta A; Hönig S; Wichert-Schmitt B; Schwarz S; Sihorsch K; Reiter C; Steinwender C
    Int J Cardiol; 2015 Feb; 181():96-101. PubMed ID: 25497527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal nerve ablation reduces augmentation index in patients with resistant hypertension.
    Hering D; Lambert EA; Marusic P; Ika-Sari C; Walton AS; Krum H; Sobotka PA; Mahfoud F; Böhm M; Lambert GW; Esler MD; Schlaich MP
    J Hypertens; 2013 Sep; 31(9):1893-900. PubMed ID: 23697964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of catheter-based renal sympathetic denervation on 24-h ambulatory blood pressure in patients with resistant hypertension.
    Völz S; Andersson B; Manhem K; Haraldsson I; Rundqvist B
    Blood Press; 2014 Aug; 23(4):228-32. PubMed ID: 24432803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure variability after catheter-based renal sympathetic denervation in patients with resistant hypertension.
    Ewen S; Dörr O; Ukena C; Linz D; Cremers B; Laufs U; Hamm C; Nef H; Bauer A; Mancia G; Böhm M; Mahfoud F
    J Hypertens; 2015 Dec; 33(12):2512-8. PubMed ID: 26485461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial.
    Mathiassen ON; Vase H; Bech JN; Christensen KL; Buus NH; Schroeder AP; Lederballe O; Rickers H; Kampmann U; Poulsen PL; Hansen KW; Btker HE; Peters CD; Engholm M; Bertelsen JB; Lassen JF; Langfeldt S; Andersen G; Pedersen EB; Kaltoft A
    J Hypertens; 2016 Aug; 34(8):1639-47. PubMed ID: 27228432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.
    Hering D; Marusic P; Walton AS; Lambert EA; Krum H; Narkiewicz K; Lambert GW; Esler MD; Schlaich MP
    Hypertension; 2014 Jul; 64(1):118-24. PubMed ID: 24732891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherence.
    Ott C; Mahfoud F; Schmid A; Ewen S; Toennes SW; Meyer MR; Helfer AG; Maurer HH; Ditting T; Veelken R; Zivanovic I; Uder M; Böhm M; Schmieder RE
    J Hypertens; 2016 Dec; 34(12):2475-2479. PubMed ID: 27607458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The randomised Oslo study of renal denervation
    Bergland OU; Søraas CL; Larstorp ACK; Halvorsen LV; Hjørnholm U; Hoffman P; Høieggen A; Fadl Elmula FEM
    Blood Press; 2021 Feb; 30(1):41-50. PubMed ID: 33030064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis.
    Scalise F; Sole A; Singh G; Sorropago A; Sorropago G; Ballabeni C; Maccario M; Vettoretti S; Grassi G; Mancia G
    J Hypertens; 2020 May; 38(5):936-942. PubMed ID: 31990900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The blood pressure-lowering effect of renal denervation is inversely related to kidney function.
    Vink EE; Verloop WL; Bost RB; Voskuil M; Spiering W; Vonken EJ; Bots ML; Blankestijn PJ
    J Hypertens; 2014 Oct; 32(10):2045-53; discussion 2053. PubMed ID: 25023158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Toennes SW; Ewen S; Ditting T; Veelken R; Ukena C; Uder M; Böhm M; Schmieder RE
    J Hypertens; 2015 Jun; 33(6):1261-6. PubMed ID: 25923731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of catheter ablation renal denervation in "mild" resistant hypertension.
    Chen S; Kiuchi MG; Acou WJ; Derndorfer M; Wang J; Li R; Kollias G; Martinek M; Kiuchi T; Pürerfellner H; Liu S
    J Clin Hypertens (Greenwich); 2017 Apr; 19(4):361-368. PubMed ID: 28266770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of multi-electrode renal sympathetic denervation on short-term blood pressure variability in patients with drug-resistant hypertension. Insights from the EnligHTN I study.
    Tsioufis C; Papademetriou V; Tsiachris D; Kasiakogias A; Kordalis A; Thomopoulos C; Dimitriadis K; Tousoulis D; Stefanadis C; Parati G; Worthley S
    Int J Cardiol; 2015 Feb; 180():237-42. PubMed ID: 25463375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does renal artery supply indicate treatment success of renal denervation?
    Schmid A; Ditting T; Sobotka PA; Veelken R; Schmieder RE; Uder M; Ott C
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):987-91. PubMed ID: 23771326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular and renal hemodynamic changes after renal denervation.
    Ott C; Janka R; Schmid A; Titze S; Ditting T; Sobotka PA; Veelken R; Uder M; Schmieder RE
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1195-201. PubMed ID: 23559677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of blood pressure response: Obesity is associated with a less pronounced treatment response after renal denervation.
    Id D; Bertog SC; Ziegler AK; Hornung M; Hofmann I; Vaskelyte L; Matic P; Gafoor S; Sievert H
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):E30-8. PubMed ID: 26104216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.